Insider Trading Alert - TIPT, BTX And WASH Traded By Insiders

Yesterday, Nov. 10, 2015, 105 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $354.40 to $12,639,826.44.

Highlighted Stocks Traded by Insiders:

Tiptree Financial (TIPT) - FREE Research Report

Barnes Michael Gene, who is Executive Chairman at Tiptree Financial, bought 5,000 shares at $7.07 on Nov. 10, 2015. Following this transaction, the Executive Chairman owned 3.2 million shares meaning that the stake was boosted by 0.16% with the 5,000-share transaction.

The shares most recently traded at $6.81, down $0.26, or 3.75% since the insider transaction. Historical insider transactions for Tiptree Financial go as follows:

  • 4-Week # shares bought: 38,900
  • 12-Week # shares bought: 132,760
  • 24-Week # shares bought: 290,063

The average volume for Tiptree Financial has been 41,900 shares per day over the past 30 days. Tiptree Financial has a market cap of $227.8 million and is part of the financial sector and insurance industry. Shares are down 14.07% year-to-date as of the close of trading on Tuesday.

TipTree Financial Inc., formerly Care Investment Trust, operates as a real estate investment trust (REIT). It engages in originating and acquiring healthcare-related real estate and commercial mortgage debt. The stock currently has a dividend yield of 1.47%.

Exclusive Offer: Get the latest Stock Analysis on TIPT - FREE

TheStreet Quant Ratings rates Tiptree Financial as a sell. The company's weaknesses can be seen in multiple areas, such as its generally high debt management risk, disappointing return on equity, weak operating cash flow, poor profit margins and generally disappointing historical performance in the stock itself. Get the full Tiptree Financial Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

BioTime (BTX) - FREE Research Report

Farrell Stephen C, who is Director at BioTime, bought 50,000 shares at $3.83 on Nov. 10, 2015. Following this transaction, the Director owned 97,450 shares meaning that the stake was boosted by 105.37% with the 50,000-share transaction.

Russell Angus C., who is Director at BioTime, bought 50,000 shares at $3.83 on Nov. 10, 2015. Following this transaction, the Director owned 67,500 shares meaning that the stake was boosted by 285.71% with the 50,000-share transaction.

The shares most recently traded at $3.50, down $0.33, or 9.43% since the insider transaction. Historical insider transactions for BioTime go as follows:

  • 4-Week # shares bought: 2,000
  • 4-Week # shares sold: 30,000
  • 12-Week # shares bought: 2,000
  • 12-Week # shares sold: 30,000
  • 24-Week # shares bought: 77,000
  • 24-Week # shares sold: 30,000

The average volume for BioTime has been 316,800 shares per day over the past 30 days. BioTime has a market cap of $295.6 million and is part of the health care sector and drugs industry. Shares are down 4.83% year-to-date as of the close of trading on Tuesday.

BioTime, Inc., a biotechnology company, engages in the research and product development in the field of regenerative medicine.

Exclusive Offer: Get the latest Stock Analysis on BTX - FREE

TheStreet Quant Ratings rates BioTime as a sell. Among the areas we feel are negative, one of the most important has been unimpressive growth in net income over time. Get the full BioTime Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Washington Trust Bancorp (WASH) - FREE Research Report

Devault David V, who is Vice Chair, Secretary and CFO at Washington Trust Bancorp, sold 2,376 shares at $41.01 on Nov. 10, 2015. Following this transaction, the Vice Chair, Secretary and CFO owned 43,796 shares meaning that the stake was reduced by 5.15% with the 2,376-share transaction.

The shares most recently traded at $40.91, down $0.10, or 0.26% since the insider transaction. Historical insider transactions for Washington Trust Bancorp go as follows:

  • 4-Week # shares bought: 150
  • 4-Week # shares sold: 1,168
  • 12-Week # shares bought: 150
  • 12-Week # shares sold: 1,168
  • 24-Week # shares bought: 150
  • 24-Week # shares sold: 13,743

The average volume for Washington Trust Bancorp has been 36,200 shares per day over the past 30 days. Washington Trust Bancorp has a market cap of $682.2 million and is part of the financial sector and banking industry. Shares are up 0.82% year-to-date as of the close of trading on Tuesday.

Washington Trust Bancorp, Inc. operates as the holding company for The Washington Trust Company that offers various banking and financial products and services to individuals and businesses. The company operates in two segments, Commercial Banking and Wealth Management Services. The stock currently has a dividend yield of 3.36%. The company has a P/E ratio of 15.7. Currently, there are no analysts who rate Washington Trust Bancorp a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on WASH - FREE

TheStreet Quant Ratings rates Washington Trust Bancorp as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, expanding profit margins, notable return on equity and solid stock price performance. We feel its strengths outweigh the fact that the company has had sub par growth in net income. Get the full Washington Trust Bancorp Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

More from Markets

Comcast Tops Disney/Fox in $40 Billion Battle for Britain's Sky TV

Comcast Tops Disney/Fox in $40 Billion Battle for Britain's Sky TV

The Products Behind Smokin' Hot Tilray

The Products Behind Smokin' Hot Tilray

FANGs Aren't Tech Stocks Any More: S&P Overhauls Sector Breakdowns

FANGs Aren't Tech Stocks Any More: S&P Overhauls Sector Breakdowns

How to Overcome the Fear of Trading Super-Momentum Stocks

How to Overcome the Fear of Trading Super-Momentum Stocks

How Closed-End Funds Use Leverage to Boost Returns

How Closed-End Funds Use Leverage to Boost Returns